Martek Announces Third Quarter 2009 Financi...(ties: Repayments of notes payable...),Health

Date:9/2/2009

ties: Repayments of notes payable and other long-term obligations, net (88) (8,888) (Payments) proceeds from equity transactions, net (302) 7,243 ---- ----- Net cash used in financing activities (390) (1,645) ---- ------ Net change in cash and cash equivalents 26,850 40,649 Cash and cash equivalents, beginning of period 102,495 16,973 ------- ------ Cash and cash equivalents, end of period $129,345 $57,622 ======== ======

'/>"/>

SOURCE Martek Biosciences Corporation Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine news :

1. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
2. Martek Announces Third Quarter 2007 Financial Results
3. Martek Announces Addition of lifesDHA(TM) to Entire Bellybar(TM) Line of Nutrition Bars
4. Martek Signs Multi-Year Infant Formula License and Supply Agreement with Alter Farmacia
5. Marteks lifesDHA(TM) Featured in New Beech-Nut(R) DHA Plus Baby Food and Cereals
6. Martek Wins German DHA Patent Infringement Actions Against Lonza and One of Nutrinovas Customers in Suits Relating to DHA Product Marketed for Use in Functional Foods and Dietary Supplements
7. Martek Signs Exclusive Worldwide Distributorship Agreement with Novus International
8. Marteks lifesDHA(TM) Featured in Dalco Foods Wellness Line Meat Products
9. Martek Announces Settlement of Class Action Lawsuit
10. Pocket Rocket Juice from Australias Boost Juice Features 700 mg of Marteks lifesDHA(TM)
11. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation